Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXD6XT
|
||||
| Drug Name |
(S)-3-cyclohexyl-1-morpholino-1-oxopropan-2-yl (S)-1-(4-(trifluoromethoxy)phenylamino)pentan-2-ylcarbamate
|
||||
| Synonyms |
CHEMBL386351
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H38F3N3O5
|
||||
| Canonical SMILES |
CCC[C@@H](CNc1ccc(OC(F)(F)F)cc1)NC(=O)O[C@@H](CC2CCCCC2)C(=O)N3CCOCC3
|
||||
| InChI |
InChI=1S/C26H38F3N3O5/c1-2-6-21(18-30-20-9-11-22(12-10-20)37-26(27,28)29)31-25(34)36-23(17-19-7-4-3-5-8-19)24(33)32-13-15-35-16-14-32/h9-12,19,21,23,30H,2-8,13-18H2,1H3,(H,31,34)/t21-,23-/m0/s1
|
||||
| InChIKey |
IHLPNVVXUCBVBS-GMAHTHKFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.